glp-1 and type 1 diabetes More people with are using drugs, study finds, despite limited evidence on safety or effectiveness GLP-1 Agonists - What is

The cohort included 111 patients (median age at GLP-1RA initiation, 15 years

Understanding this connection requires a closer look at how GLP-1 drugs work in the brain beyond appetite suppression

Early detection through regular screening is critical to preventing colon cancer and improving outcomes

Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease

This study was corroborated by another study by Diamant et al., where HDL-C levels nonsignificantly changed from the baseline following treatment with exenatide once weekly (0.00 mmol/L) [67]

Overall, LV mass index remained stable during treatment